JP4693474B2 - ヒトや動物の生体中の被験成分濃度をモニタリングする方法並びにその装置 - Google Patents
ヒトや動物の生体中の被験成分濃度をモニタリングする方法並びにその装置 Download PDFInfo
- Publication number
- JP4693474B2 JP4693474B2 JP2005117542A JP2005117542A JP4693474B2 JP 4693474 B2 JP4693474 B2 JP 4693474B2 JP 2005117542 A JP2005117542 A JP 2005117542A JP 2005117542 A JP2005117542 A JP 2005117542A JP 4693474 B2 JP4693474 B2 JP 4693474B2
- Authority
- JP
- Japan
- Prior art keywords
- test component
- value
- time
- function
- values
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 title claims description 85
- 238000000034 method Methods 0.000 title claims description 34
- 241001465754 Metazoa Species 0.000 title claims description 11
- 238000012544 monitoring process Methods 0.000 title claims description 8
- 238000005259 measurement Methods 0.000 claims description 36
- 238000012545 processing Methods 0.000 claims description 5
- 238000001727 in vivo Methods 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 230000008859 change Effects 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 235000008429 bread Nutrition 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004020160.9 | 2004-04-24 | ||
| DE102004020160A DE102004020160A1 (de) | 2004-04-24 | 2004-04-24 | Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005308742A JP2005308742A (ja) | 2005-11-04 |
| JP2005308742A5 JP2005308742A5 (https=) | 2010-11-11 |
| JP4693474B2 true JP4693474B2 (ja) | 2011-06-01 |
Family
ID=34934888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005117542A Expired - Fee Related JP4693474B2 (ja) | 2004-04-24 | 2005-04-14 | ヒトや動物の生体中の被験成分濃度をモニタリングする方法並びにその装置 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7188034B2 (https=) |
| EP (1) | EP1589438B1 (https=) |
| JP (1) | JP4693474B2 (https=) |
| CA (1) | CA2504661C (https=) |
| DE (1) | DE102004020160A1 (https=) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| AU2002315180A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Electric lancet actuator |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| DE60234598D1 (de) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A LANZETTING DEVICE INTEGRATED ON A BLOOD CARTRIDGE CARTRIDGE |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| DE602004028463D1 (de) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | Verfahren und vorrichtung zur injektion von flüssigkeit |
| WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A VARIABLE USER INTERFACE |
| EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| WO2006011062A2 (en) | 2004-05-20 | 2006-02-02 | Albatros Technologies Gmbh & Co. Kg | Printable hydrogel for biosensors |
| WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| EP1728468A1 (de) * | 2005-06-04 | 2006-12-06 | Roche Diagnostics GmbH | Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung |
| WO2008017981A2 (en) * | 2006-08-08 | 2008-02-14 | Koninklijke Philips Electronics N.V. | Method and device for monitoring a physiological parameter |
| US8439837B2 (en) * | 2006-10-31 | 2013-05-14 | Lifescan, Inc. | Systems and methods for detecting hypoglycemic events having a reduced incidence of false alarms |
| EP3391812B1 (en) * | 2007-01-23 | 2025-01-01 | Ascensia Diabetes Care Holdings AG | Analyte-testing device |
| EP1967132B8 (de) | 2007-03-09 | 2015-06-03 | Roche Diagnostics GmbH | Medizinisches Datenübertragungssystem |
| US20090160656A1 (en) * | 2007-10-11 | 2009-06-25 | Mahesh Seetharaman | Analyte monitoring system alarms |
| DE102007046864A1 (de) * | 2007-09-28 | 2009-04-09 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Verfahren und Vorrichtung zur Bewertung eines Messwertes |
| US7731659B2 (en) * | 2007-10-18 | 2010-06-08 | Lifescan Scotland Limited | Method for predicting a user's future glycemic state |
| US7695434B2 (en) * | 2007-10-19 | 2010-04-13 | Lifescan Scotland, Ltd. | Medical device for predicting a user's future glycemic state |
| WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
| WO2010014963A2 (en) * | 2008-07-31 | 2010-02-04 | Government Of The United States As Represented By The Secretary Of The Army | Universal models for predicting glucose concentration in humans |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| JP5410511B2 (ja) | 2009-04-17 | 2014-02-05 | アークレイ株式会社 | 情報提供システム、情報提供方法、プログラム及びサーバ装置 |
| US8843321B2 (en) * | 2010-01-26 | 2014-09-23 | Roche Diagnostics Operations, Inc. | Methods and systems for processing glucose data measured from a person having diabetes |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| EP2700031A2 (en) * | 2011-04-20 | 2014-02-26 | Novo Nordisk A/S | Glucose predictor based on regularization networks with adaptively chosen kernels and regularization parameters |
| KR101962315B1 (ko) * | 2017-03-29 | 2019-07-17 | 이화여자대학교 산학협력단 | 혈중수은농도 예측방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI931234A7 (fi) | 1993-03-19 | 1994-09-20 | Instr Oy | Menetelmä potilaan tilan seuraamiseksi |
| KR0142483B1 (ko) | 1994-02-28 | 1998-08-17 | 고지마 게이지 | 시계열 데이타의 단기 예측을 실행하기 위한 방법 및 장치 |
| DE4415896A1 (de) | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysesystem zur Überwachung der Konzentration eines Analyten im Blut eines Patienten |
| EP0910023A2 (de) * | 1997-10-17 | 1999-04-21 | Siemens Aktiengesellschaft | Verfahren und Anordnung zur neuronalen Modellierung eines dynamischen Systems mit nichtlinearem stochastischem Verhalten |
| JPH11296598A (ja) | 1998-04-07 | 1999-10-29 | Seizaburo Arita | 血糖値の予測システム及び予測方法並びにこの方法を記録した記録媒体 |
| EP1078258B1 (en) | 1998-05-13 | 2003-07-30 | Cygnus, Inc. | Device for predicting physiological values |
| US6925393B1 (en) | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
| JP3563333B2 (ja) | 2000-08-04 | 2004-09-08 | Necエレクトロニクス株式会社 | インラッシュ電流対応ハイサイドスイッチ及び過電流制御方法 |
| ES2304394T3 (es) | 2000-08-18 | 2008-10-16 | Animas Technologies Llc | Dispositivo para la prediccion de eventos hipoglucemicos. |
| EP1702561B1 (en) | 2002-03-22 | 2011-05-04 | Animas Technologies LLC | Improving performance for an analyte monitoring device |
| US7278983B2 (en) * | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
| AU2003259741B2 (en) | 2002-08-13 | 2008-10-23 | University Of Virginia Patent Foundation | Managing and processing self-monitoring blood glucose |
| DE10343863A1 (de) * | 2003-09-23 | 2005-04-14 | Roche Diagnostics Gmbh | Verfahren und Gerät zur laufenden Überwachung der Konzentration eines Analyten |
| US20070060870A1 (en) * | 2005-08-16 | 2007-03-15 | Tolle Mike Charles V | Controller device for an infusion pump |
| US20070060869A1 (en) * | 2005-08-16 | 2007-03-15 | Tolle Mike C V | Controller device for an infusion pump |
-
2004
- 2004-04-24 DE DE102004020160A patent/DE102004020160A1/de not_active Withdrawn
-
2005
- 2005-04-08 EP EP05007701.5A patent/EP1589438B1/de not_active Expired - Lifetime
- 2005-04-14 JP JP2005117542A patent/JP4693474B2/ja not_active Expired - Fee Related
- 2005-04-21 CA CA002504661A patent/CA2504661C/en not_active Expired - Fee Related
- 2005-04-25 US US11/113,606 patent/US7188034B2/en not_active Expired - Lifetime
-
2007
- 2007-02-15 US US11/675,580 patent/US7650244B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2504661C (en) | 2009-08-18 |
| EP1589438B1 (de) | 2015-11-04 |
| US7650244B2 (en) | 2010-01-19 |
| EP1589438A2 (de) | 2005-10-26 |
| DE102004020160A1 (de) | 2005-11-10 |
| US20050240356A1 (en) | 2005-10-27 |
| CA2504661A1 (en) | 2005-10-24 |
| US20070148778A1 (en) | 2007-06-28 |
| JP2005308742A (ja) | 2005-11-04 |
| EP1589438A3 (de) | 2006-03-22 |
| US7188034B2 (en) | 2007-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4693474B2 (ja) | ヒトや動物の生体中の被験成分濃度をモニタリングする方法並びにその装置 | |
| JP6408479B2 (ja) | 患者モニタリングシステム及び患者モニタリング方法 | |
| EP2408354B1 (en) | Systems and methods for monitoring heart rate and blood pressure correlation | |
| US7731659B2 (en) | Method for predicting a user's future glycemic state | |
| US7292883B2 (en) | Physiological assessment system | |
| US9615781B2 (en) | Systems and methods for monitoring depth of consciousness | |
| EP3358485A1 (en) | General noninvasive blood glucose prediction method based on timing analysis | |
| AU2011213041B2 (en) | System and method for diagnosing sleep apnea based on results of multiple approaches to sleep apnea identification | |
| US20090088606A1 (en) | Systems and methods for patient specific adaptable telemonitoring alerts | |
| Verdru et al. | Wearable seizure detection devices in refractory epilepsy | |
| EP4221590B1 (en) | Oxygen saturation monitoring using artificial intelligence | |
| US7678047B2 (en) | Chaologic brain function diagnosis apparatus | |
| US20160183886A1 (en) | Biological information predicting apparatus and biological information predicting method | |
| US11580432B2 (en) | System monitor and method of system monitoring to predict a future state of a system | |
| US12097007B2 (en) | Interactive health-monitoring platform for wearable wireless sensor systems | |
| JP2016529989A (ja) | データ点のストリーム内で平滑化されたデータ点を判定する方法及び装置 | |
| JP6318047B2 (ja) | 疾病予測装置、及びプログラム | |
| CN106264478A (zh) | 监护系统、体温监测仪及其人体体温数据处理方法及装置 | |
| CN118940015A (zh) | 一种基于大数据的社区养老服务管理方法 | |
| CN109414201A (zh) | 生物信息测定辅助装置、生物信息测定装置、生物信息测定辅助方法和辅助程序 | |
| KR102035731B1 (ko) | 광용적맥파를 이용한 통증심도 측정 방법 및 장치 | |
| JP4451297B2 (ja) | 生体情報検出装置 | |
| KR20150142557A (ko) | 의료기기 안전제어 장치 및 이를 이용한 의료기기 | |
| CN116473524B (zh) | 一种基于光感传感器检测血管硬化参数的方法及系统 | |
| US12575748B2 (en) | Blood pressure-related information display device, blood pressure-related information display method, and a non-transitory computer- readable computer medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20061228 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070410 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070709 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070712 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070809 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070814 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070907 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080401 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080724 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20080909 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20081003 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080904 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100126 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100129 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100326 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100331 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20100525 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100824 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100827 |
|
| A524 | Written submission of copy of amendment under section 19 (pct) |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20100927 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110118 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110222 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140304 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |